Giuseppe Motta

Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience

P. Migliorini, S. Galimberti, F. Pratesi, 2022, Clinical and Experimental Medicine.

Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies

P. Migliorini, G. Masi, F. Salani, 2023, International Journal of Clinical Oncology.

Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience

P. Migliorini, S. Galimberti, F. Pratesi, 2022, Clinical and Experimental Medicine.